New Hampshire 2026 Session Status: Passed Senate 8 R cosponsors

SB 465 — classifying xylazine as a schedule III controlled drug.

Last action — Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced November 21, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the House.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 38% · moderate confidence

  • Passed Senate

    Current position in the legislative process.

  • 10 sponsors

    1 primary, 9 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (8 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

classifying xylazine as a schedule III controlled drug.

Bill Text

What changed in the latest version

19 added · 7 removed

Plain-language change summary

The recent amendments to SB 465 specify that xylazine, a drug, will be scheduled for regulation while also allowing licensed veterinarians to prescribe and administer it to nonhuman animals. This modification highlights the drug's use in veterinary medicine and ensures that veterinarians can continue to treat animals without interruption. This change is significant as it balances public health concerns with the needs of animal care, ensuring that animals can receive necessary medical treatment while still regulating the drug's use.

→
Previous
Latest
SB 465-FN - AS INTRODUCED SESSION 26-2002 09/05 SENATE BILL 465-FN AN ACT classifying xylazine as a schedule III controlled drug.
SB 465-FN - AS AMENDED BY THE SENATE 03/05/2026 0842s SESSION 26-2002 09/05 SENATE BILL 465-FN AN ACT classifying xylazine as a schedule III controlled drug.
SB 465-FN - AS INTRODUCED 26-2002 09/05 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT classifying xylazine as a schedule III controlled drug.
SB 465-FN - AS AMENDED BY THE SENATE 03/05/2026 0842s 26-2002 09/05 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT classifying xylazine as a schedule III controlled drug.
I.
II.
Notwithstanding paragraph I, nothing in this section shall prevent any licensed veterinarian, as defined in RSA 332-B:1, from doing any of the following:
(a) Dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the Secretary of Health and Human Services under section 512 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
section 360b.
(b) Dispensing or prescribing for, or administering to, a nonhuman species that is permissible under section 512(a)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
section 360b(a)(4).
(c) Another use that is approved or permissible under the Federal Food, Drug, and Cosmetic Act.
LBA 26-2002 11/16/25 SB 465-FN- FISCAL NOTE AS INTRODUCED AN ACT classifying xylazine as a schedule III controlled drug.
LBA 26-2002 04/06/2026 SB 465-FN- FISCAL NOTE AS AMENDED BY THE SENATE (AMENDMENT #2026-0842s) AN ACT classifying xylazine as a schedule III controlled drug.
⬇ Download PDF
View plain text versions (2)

Action History

  1. Inexpedient to Legislate: MA VV 04/23/2026 HJ 11

  2. Minority Committee Report: Ought to Pass

  3. Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)

  4. Executive Session: 04/14/2026 01:00 pm GP 153

  5. Full Committee Work Session: 04/07/2026 01:00 pm GP 153

  6. Public Hearing: 03/31/2026 01:30 pm GP 153

  7. Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8 P. 114

  8. Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5

  9. Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5

  10. Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8

  11. Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A

  12. Introduced 01/07/2026 and Referred to Judiciary; SJ 1

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 405 not signed on

Sponsors (1)

Co-sponsors (9)

Not signed on (405)

405 members have not signed on to this bill.

Show all 405 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 465 do?
classifying xylazine as a schedule III controlled drug.
Who sponsors SB 465?
SB 465 is sponsored by Mark McConkey (Republican), David Rochefort (Republican), Lilli Walsh (Republican), Daryl Abbas (Republican), Jennifer M Rhodes, Terry W Roy, Bill Gannon (Republican), Regina Birdsell (Republican), Michael Vose (Republican), and Sharon Carson (Republican).
What is the current status of SB 465?
This bill has passed the Senate. Introduced November 21, 2025. It now moves to the second chamber.
Where can I track SB 465?
Track SB 465 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 465

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 465

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →